Cargando…

miR-1/206 downregulates splicing factor Srsf9 to promote C2C12 differentiation

BACKGROUND: Myogenesis is driven by specific changes in the transcriptome that occur during the different stages of muscle differentiation. In addition to controlled transcriptional transitions, several other post-transcriptional mechanisms direct muscle differentiation. Both alternative splicing an...

Descripción completa

Detalles Bibliográficos
Autores principales: Bjorkman, Kristen K., Buvoli, Massimo, Pugach, Emily K., Polmear, Michael M., Leinwand, Leslie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888935/
https://www.ncbi.nlm.nih.gov/pubmed/31791406
http://dx.doi.org/10.1186/s13395-019-0211-4
_version_ 1783475329358102528
author Bjorkman, Kristen K.
Buvoli, Massimo
Pugach, Emily K.
Polmear, Michael M.
Leinwand, Leslie A.
author_facet Bjorkman, Kristen K.
Buvoli, Massimo
Pugach, Emily K.
Polmear, Michael M.
Leinwand, Leslie A.
author_sort Bjorkman, Kristen K.
collection PubMed
description BACKGROUND: Myogenesis is driven by specific changes in the transcriptome that occur during the different stages of muscle differentiation. In addition to controlled transcriptional transitions, several other post-transcriptional mechanisms direct muscle differentiation. Both alternative splicing and miRNA activity regulate gene expression and production of specialized protein isoforms. Importantly, disruption of either process often results in severe phenotypes as reported for several muscle diseases. Thus, broadening our understanding of the post-transcriptional pathways that operate in muscles will lay the foundation for future therapeutic interventions. METHODS: We employed bioinformatics analysis in concert with the well-established C2C12 cell system for predicting and validating novel miR-1 and miR-206 targets engaged in muscle differentiation. We used reporter gene assays to test direct miRNA targeting and studied C2C12 cells stably expressing one of the cDNA candidates fused to a heterologous, miRNA-resistant 3′ UTR. We monitored effects on differentiation by measuring fusion index, myotube area, and myogenic gene expression during time course differentiation experiments. RESULTS: Gene ontology analysis revealed a strongly enriched set of putative miR-1 and miR-206 targets associated with RNA metabolism. Notably, the expression levels of several candidates decreased during C2C12 differentiation. We discovered that the splicing factor Srsf9 is a direct target of both miRNAs during myogenesis. Persistent Srsf9 expression during differentiation impaired myotube formation and blunted induction of the early pro-differentiation factor myogenin as well as the late differentiation marker sarcomeric myosin, Myh8. CONCLUSIONS: Our data uncover novel miR-1 and miR-206 cellular targets and establish a functional link between the splicing factor Srsf9 and myoblast differentiation. The finding that miRNA-mediated clearance of Srsf9 is a key myogenic event illustrates the coordinated and sophisticated interplay between the diverse components of the gene regulatory network.
format Online
Article
Text
id pubmed-6888935
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68889352019-12-11 miR-1/206 downregulates splicing factor Srsf9 to promote C2C12 differentiation Bjorkman, Kristen K. Buvoli, Massimo Pugach, Emily K. Polmear, Michael M. Leinwand, Leslie A. Skelet Muscle Research BACKGROUND: Myogenesis is driven by specific changes in the transcriptome that occur during the different stages of muscle differentiation. In addition to controlled transcriptional transitions, several other post-transcriptional mechanisms direct muscle differentiation. Both alternative splicing and miRNA activity regulate gene expression and production of specialized protein isoforms. Importantly, disruption of either process often results in severe phenotypes as reported for several muscle diseases. Thus, broadening our understanding of the post-transcriptional pathways that operate in muscles will lay the foundation for future therapeutic interventions. METHODS: We employed bioinformatics analysis in concert with the well-established C2C12 cell system for predicting and validating novel miR-1 and miR-206 targets engaged in muscle differentiation. We used reporter gene assays to test direct miRNA targeting and studied C2C12 cells stably expressing one of the cDNA candidates fused to a heterologous, miRNA-resistant 3′ UTR. We monitored effects on differentiation by measuring fusion index, myotube area, and myogenic gene expression during time course differentiation experiments. RESULTS: Gene ontology analysis revealed a strongly enriched set of putative miR-1 and miR-206 targets associated with RNA metabolism. Notably, the expression levels of several candidates decreased during C2C12 differentiation. We discovered that the splicing factor Srsf9 is a direct target of both miRNAs during myogenesis. Persistent Srsf9 expression during differentiation impaired myotube formation and blunted induction of the early pro-differentiation factor myogenin as well as the late differentiation marker sarcomeric myosin, Myh8. CONCLUSIONS: Our data uncover novel miR-1 and miR-206 cellular targets and establish a functional link between the splicing factor Srsf9 and myoblast differentiation. The finding that miRNA-mediated clearance of Srsf9 is a key myogenic event illustrates the coordinated and sophisticated interplay between the diverse components of the gene regulatory network. BioMed Central 2019-12-02 /pmc/articles/PMC6888935/ /pubmed/31791406 http://dx.doi.org/10.1186/s13395-019-0211-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Bjorkman, Kristen K.
Buvoli, Massimo
Pugach, Emily K.
Polmear, Michael M.
Leinwand, Leslie A.
miR-1/206 downregulates splicing factor Srsf9 to promote C2C12 differentiation
title miR-1/206 downregulates splicing factor Srsf9 to promote C2C12 differentiation
title_full miR-1/206 downregulates splicing factor Srsf9 to promote C2C12 differentiation
title_fullStr miR-1/206 downregulates splicing factor Srsf9 to promote C2C12 differentiation
title_full_unstemmed miR-1/206 downregulates splicing factor Srsf9 to promote C2C12 differentiation
title_short miR-1/206 downregulates splicing factor Srsf9 to promote C2C12 differentiation
title_sort mir-1/206 downregulates splicing factor srsf9 to promote c2c12 differentiation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888935/
https://www.ncbi.nlm.nih.gov/pubmed/31791406
http://dx.doi.org/10.1186/s13395-019-0211-4
work_keys_str_mv AT bjorkmankristenk mir1206downregulatessplicingfactorsrsf9topromotec2c12differentiation
AT buvolimassimo mir1206downregulatessplicingfactorsrsf9topromotec2c12differentiation
AT pugachemilyk mir1206downregulatessplicingfactorsrsf9topromotec2c12differentiation
AT polmearmichaelm mir1206downregulatessplicingfactorsrsf9topromotec2c12differentiation
AT leinwandlesliea mir1206downregulatessplicingfactorsrsf9topromotec2c12differentiation